APPEALS NOTED
FEDERAL COURT OF APPEAL
Innovative Medicines Canada v. Canada (Attorney General), 2020 FC 725, [2020] 4 F.C.R. 180, has been affirmed on appeal (A-215-20, 2022 FCA 210). The reasons for judgment, handed down December 5, 2022, will be published in the Federal Courts Reports.
SUPREME COURT OF CANADA
Applications for leave to appeal
Abi-Mansour v. Canada (Attorney General), A-56-21, Near J.A., order dated July 20, 2021, leave to appeal to S.C.C. refused December 15, 2022.
Abi-Mansour v. Canada (Attorney General), A-79-21, Stratas, Locke and Monaghan JJ.A., order dated October 13, 2021, leave to appeal to S.C.C. refused December 15, 2022.
Cliff v. Canada, A-265-19, A-266-19, 2022 FCA 16, Rennie J.A., judgment dated February 1, 2022, leave to appeal to S.C.C. refused December 8, 2022.
Doyle v. Canada (Attorney General), A-76-20, 2022 FCA 56, Stratas J.A., judgment dated March 30, 2022, leave to appeal to S.C.C. refused December 15, 2022.
Iristel Inc. v. Telus Communications Inc., 21-A-31, de Montigny, Rivoalen and Locke JJ.A., order dated March 7, 2022, leave to appeal to S.C.C. refused December 8, 2022.
Landau v. Canada (Attorney General), A-270-20, 2022 FCA 12, Stratas J.A., judgment dated January 25, 2022, leave to appeal to S.C.C. refused December 8, 2022.